<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04891133</url>
  </required_header>
  <id_info>
    <org_study_id>EU SolidAct</org_study_id>
    <secondary_id>2021-000541-41</secondary_id>
    <nct_id>NCT04891133</nct_id>
  </id_info>
  <brief_title>EU SolidAct: An Adaptive Pandemic and Emerging Infection Platform Trial</brief_title>
  <official_title>European DisCoVeRy for Solidarity: An Adaptive Pandemic and Emerging Infection Platform Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Oslo University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Institut National de la Santé Et de la Recherche Médicale, France</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Epidemiological and Clinical Research Information Network</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Oslo University Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      EU SolidAct is a randomized, multifactorial, adaptive platform trial for COVID-19 and&#xD;
      emerging infectious diseases and pandemics. The purpose of this study is to evaluate the&#xD;
      effect of a range of interventions to improve outcome of patients admitted to hospital with&#xD;
      COVID-19. The platform is designed for running phase 2 and phase 3 trials, and with modular&#xD;
      data capture (end point/safety data, biobanking, add-on studies) depending on the capacity of&#xD;
      participating sites. The study consists of two parts with different primary end points&#xD;
      depending on disease stage: EU SolidAct part A includes hospitalized patients with moderate&#xD;
      disease, whereas EU SolidAct part B includes hospitalized patients with severe and critical&#xD;
      disease.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      There is an urgent need for developing an adaptive pan-European research platform for rapid&#xD;
      and coordinated investigation of new candidate drugs during ongoing pandemics. EU-SolidAct is&#xD;
      an Adaptive Platform Trial master protocol developed for evaluating drug interventions in&#xD;
      hospitalized patients with COVID-19. While this master protocol is developed for therapeutic&#xD;
      interventions in hospitalized patients, it could also form the basis for trial protocols on&#xD;
      other interventions and/or in non-hospitalized populations. The protocol is additionally&#xD;
      developed to facilitate a joint European response to the challenge of evaluating&#xD;
      interventions during future epidemics. The described disease states and endpoints may need to&#xD;
      be adapted to the epidemic in question.&#xD;
&#xD;
      EU-SolidAct is a European, multicentre, randomized, parallel, phase 2 and 3 platform trial on&#xD;
      drug interventions, both new and repurposed, single or in combination, in hospitalized adult&#xD;
      patients with moderate or severe COVID-19, as defined by the WHO Working Group on the&#xD;
      Clinical Characterisation and Management of COVID-191. Participants with moderate disease&#xD;
      (WHO score 4-5) will be eligible for EU-SolidAct Part A, whereas participants with&#xD;
      severe/critical disease (WHO score 6-9) will be eligible for EU-SolidAct Part B. This might&#xD;
      include participants progressing from Part A.&#xD;
&#xD;
      In Part A of phase 3 confirmatory trials, the primary objective is to determine the effect of&#xD;
      therapeutic interventions on occurrence of disease progression, from moderate disease to&#xD;
      severe/critical disease or death within 14 days. In Part B, the primary objective is to&#xD;
      determine the effect of therapeutic interventions on occurrence of death within 60 days.&#xD;
&#xD;
      In phase 2 the default objective for both parts is to explore the effect of the therapeutic&#xD;
      intervention on respiratory dysfunction at day 5. Other objectives, e.g. effect on&#xD;
      virological outcomes may be considered based on the treatment mode of action.&#xD;
&#xD;
      In phase 3 trials, both superiority and non-inferiority hypotheses may be evaluated. In phase&#xD;
      2 trials, only superiority hypotheses will be evaluated. In addition to single treatments,&#xD;
      combination of treatments could also be assessed through factorial design. EU-SolidAct is&#xD;
      designed to be adaptive and to enable inclusion of hospitals in Europe and beyond, regardless&#xD;
      of epidemic waves and available resources. This requires the master protocol to be modular,&#xD;
      ranging from a core set of outcomes to more advanced data capture. Hospitals will access the&#xD;
      study on different pre-set levels, ranging from a core set of clinical endpoints and safety&#xD;
      measures, to a more advanced level with biobanking and possibilities for add-on studies&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 3, 2021</start_date>
  <completion_date type="Anticipated">December 2025</completion_date>
  <primary_completion_date type="Anticipated">December 2022</primary_completion_date>
  <phase>Phase 2/Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
    <masking_description>Corresponding placebo tablets</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Occurrence of death within 60 days (primary end point, EU SolidAct part B)</measure>
    <time_frame>60 days</time_frame>
    <description>The primary outcome for phase 3 trials in EU SolidAct part B is occurrence of death within 60 days</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Occurrence of disease progression within 14 days (primary end point, EU SolidAct part A)</measure>
    <time_frame>14 days</time_frame>
    <description>The primary outcome for phase 3 trials in EU SolidAct part A is occurrence of disease progression, defined as a progression of disease state from moderate (WHO score 4-5) to severe/critical (WHO score 6-9) or death (WHO score 10)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>SpO2/FiO2-ratio at day 5 (primary end point, phase 2 trials)</measure>
    <time_frame>5 days</time_frame>
    <description>In phase 2 exploratory trials, the default primary objective for both part A and B is to explore the effect of the intervention on respiratory dysfunction assessed by SpO2/FiO2-ratio at day 5</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Occurrence of disease progression within 28 days (shared secondary end point for part A and B)</measure>
    <time_frame>28 days</time_frame>
    <description>Occurrence of disease progression, defined as a progression of disease state from moderate (WHO score 4-5) to severe/critical/death (WHO score 6-10) or from severe/critical (WHO score 6-9) to death</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to sustained recovery (shared secondary end point for part A and B)</measure>
    <time_frame>90 days</time_frame>
    <description>Time from randomization to sustained recovery, defined as being discharged from the index hospitalization, followed by being alive and at home for 14 consecutive days within 90 days</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to first hospital discharge (shared secondary end point for part A and B)</measure>
    <time_frame>90 days</time_frame>
    <description>Time from randomization to first hospital discharge within 90 days</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Disease state at Day 15 and Day 29 (shared secondary end point for part A and B)</measure>
    <time_frame>28 days</time_frame>
    <description>Disease state on a 5-point scale defined as:&#xD;
Mild (WHO score 1-3) or better,&#xD;
Moderate (WHO score 4-5),&#xD;
Severe (WHO score 6),&#xD;
Critical (WHO score 7-9) or&#xD;
Death at Day 15 and 29</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time from randomization to recovery (shared secondary end point for part A and B)</measure>
    <time_frame>90 days</time_frame>
    <description>Time from randomization to recovery defined as no need for oxygen</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>SpO2/FiO2-ratio at Day 3, 5 and 8 (shared secondary end point for part A and B)</measure>
    <time_frame>8 days</time_frame>
    <description>Respiratory dysfunction assessed by SpO2/FiO2-ratio at Day 3, 5 and 8</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Viral clearance during hospitalization (shared secondary end point for part A and B)</measure>
    <time_frame>Days 1, 3, 5, 8 and 15</time_frame>
    <description>Viral clearance as assessed by SARS-CoV-2 PCR in naso/oropharyngeal specimens collected at Days 1, 3, 5, 8 and 15 (± 1 day, except baseline) if still hospitalized</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Occurrence of serious adverse events within 90 days (shared secondary end point for part A and B)</measure>
    <time_frame>90 days</time_frame>
    <description>Occurrence of serious adverse events leading to study treatment discontinuation or death</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient related outcomes at day 90 (shared secondary end point for part A and B)</measure>
    <time_frame>90 days</time_frame>
    <description>The Oslo COVID-19 QLQ-PW80 subscale scores at Day 90</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Changes in C-reactive protein from baseline</measure>
    <time_frame>Days 1, 3, 5, 8, 15 and 22</time_frame>
    <description>Analyzed in blood samples collected at Days 1, 3, 5, 8, 15 and 22 (± 1 day) if still hospitalized</description>
  </other_outcome>
  <other_outcome>
    <measure>Changes in Ferritin from baseline</measure>
    <time_frame>Days 1, 3, 5, 8, 15 and 22</time_frame>
    <description>Analyzed in blood samples collected at Days 1, 3, 5, 8, 15 and 22 (± 1 day) if still hospitalized</description>
  </other_outcome>
  <other_outcome>
    <measure>Changes in Lactate dehydrogenase from baseline</measure>
    <time_frame>Days 1, 3, 5, 8, 15 and 22</time_frame>
    <description>Analyzed in blood samples collected at Days 1, 3, 5, 8, 15 and 22 (± 1 day) if still hospitalized</description>
  </other_outcome>
  <other_outcome>
    <measure>Changes in D-dimer from baseline</measure>
    <time_frame>Days 1, 3, 5, 8, 15 and 22</time_frame>
    <description>Analyzed in blood samples collected at Days 1, 3, 5, 8, 15 and 22 (± 1 day) if still hospitalized</description>
  </other_outcome>
  <other_outcome>
    <measure>Changes in procalcitonin from baseline</measure>
    <time_frame>Days 1, 3, 5, 8, 15 and 22</time_frame>
    <description>Analyzed in blood samples collected at Days 1, 3, 5, 8, 15 and 22 (± 1 day) if still hospitalized</description>
  </other_outcome>
  <other_outcome>
    <measure>Changes in neutrophils from baseline</measure>
    <time_frame>Days 1, 3, 5, 8, 15 and 22</time_frame>
    <description>Analyzed in blood samples collected at Days 1, 3, 5, 8, 15 and 22 (± 1 day) if still hospitalized</description>
  </other_outcome>
  <other_outcome>
    <measure>Changes in lymphocytes from baseline</measure>
    <time_frame>Days 1, 3, 5, 8, 15 and 22</time_frame>
    <description>Analyzed in blood samples collected at Days 1, 3, 5, 8, 15 and 22 (± 1 day) if still hospitalized</description>
  </other_outcome>
  <other_outcome>
    <measure>Changes in White Blood Cell Count from baseline</measure>
    <time_frame>Days 1, 3, 5, 8, 15 and 22</time_frame>
    <description>Analyzed in blood samples collected at Days 1, 3, 5, 8, 15 and 22 (± 1 day) if still hospitalized</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">1900</enrollment>
  <condition>COVID-19</condition>
  <condition>Emerging Infectious Disease</condition>
  <arm_group>
    <arm_group_label>Active arm</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>4mg Baricitinib up to 14 days + SoC</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Comparator</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Matching placebo up to 14 days + SoC</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Baricitinib</intervention_name>
    <description>4 mg baricitinib (2 tablets of 2 mg) once daily</description>
    <arm_group_label>Active arm</arm_group_label>
    <other_name>Olumiant</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>4 mg placebo (2 tablets of 2 mg) once daily</description>
    <arm_group_label>Comparator</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        EU SOLIDACT PLATFORM INCLUSION CRITERIA:&#xD;
&#xD;
        Participants are eligible to be included in the study only if all the following general&#xD;
        inclusion (GI) criteria apply:&#xD;
&#xD;
          -  GI1. ≥ 18 years of age&#xD;
&#xD;
          -  GI2. Laboratory-confirmed SARS-CoV-2 infection (new infection or reinfection) as&#xD;
             determined by PCR not more than 9 days old.&#xD;
&#xD;
          -  GI3. Admitted to hospital&#xD;
&#xD;
          -  GI4. Informed consent by the participant or legally authorized representative&#xD;
&#xD;
          -  GI5A (SolidAct part A): Moderate disease state defined as hospitalised patients&#xD;
             without oxygen therapy or oxygen by mask or nasal prongs needed, or&#xD;
&#xD;
          -  GI5B (SolidAct part B): Severe/critical disease state defined as fulfilling at least&#xD;
             one of the following criteria:&#xD;
&#xD;
               1. SpO2&lt;90% on room air, or&#xD;
&#xD;
               2. SpO2 90-94% with a downwards trend and/or signs of respiratory distress*, or&#xD;
&#xD;
               3. Need of oxygen by NIV (CPAP, BIPAP), high flow or non-rebreather mask, or&#xD;
&#xD;
               4. Need of mechanical ventilation/ECMO&#xD;
&#xD;
                  *persistently increased respiratory rate, use of accessory muscles, inability to&#xD;
                  complete full sentences. Clinical judgement must be applied to determine whether&#xD;
                  a low oxygen saturation is indicative of disease progression or severity or is&#xD;
                  habitual for a given patient (i.e., with underlying chronic lung disease).&#xD;
&#xD;
                  NIV=non-invasive ventilation. CPAP= Continuous Positive Airway Pressure, BPAP=&#xD;
                  Bi-level Positive Airway Pressure, ECMO = extracorporeal membrane oxygenation.&#xD;
&#xD;
                  Additional inclusion criteria are given in the intervention-specific&#xD;
                  sub-protocols.&#xD;
&#xD;
                  EU SOLIDACT PLATFORM EXCLUSION CRITERIA:&#xD;
&#xD;
                  Participants are excluded from the study if any of the following general&#xD;
                  exclusion criteria (GE) apply:&#xD;
&#xD;
          -  GE1. Anticipated transfer to another non-trial hospital within 72 hours&#xD;
&#xD;
        Additional exclusion criteria, including prohibited medication, confounding trials and&#xD;
        details on contraception and pregnancy are given in the intervention-specific sub-protocols&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Domique Costagliola, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Institut National de la Santé Et de la Recherche Médicale, France</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jose R Arribas, MD PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital Universario La Paz, Madrid</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Marius Trøseid, MD PhD</last_name>
    <phone>+4792440240</phone>
    <email>marius.troseid@medisin.uio.no</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Inge C Olsen, PhD</last_name>
    <phone>+4741459597</phone>
    <email>inge.christoffer.olsen@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Medical University of Innsbruck (University Hospital for Neurosurgery)</name>
      <address>
        <city>Innsbruck</city>
        <zip>6020</zip>
        <country>Austria</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Claudius Thomé, Prof</last_name>
      <email>claudius.thome@i-med.ac.at</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Medical Unversity of Innsbruck (Joint Institute for Emergency Medicine and Critical Care)</name>
      <address>
        <city>Innsbruck</city>
        <zip>6020</zip>
        <country>Austria</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Michael Joannidis, Prof</last_name>
      <email>michael.joannidis@i-med.ac.at</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Medical Unversity of Innsbruck (University Hospital for Anaesthesia and Intensive Care)</name>
      <address>
        <city>Innsbruck</city>
        <zip>6020</zip>
        <country>Austria</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Robert Breitkopf</last_name>
      <email>robert.breitkopf@tirol-kliniken.at</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Erasme Hospital</name>
      <address>
        <city>Brussels</city>
        <zip>1070</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Maya Hites</last_name>
      <email>maya.hites@erasme.ulb.ac.be</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>UZ Brussel</name>
      <address>
        <city>Brussels</city>
        <zip>1090</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Lucie Seyler</last_name>
      <email>lucie.seyler@uzbrussel.be</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Cliniques Universitaires Saint-Luc</name>
      <address>
        <city>Brussels</city>
        <zip>1200</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Leïla Belkhir</last_name>
      <email>leila.belkhir@uclouvain.be</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHU Saint-Pierre</name>
      <address>
        <city>Brussel</city>
        <zip>1000</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Nicolas Dauby</last_name>
      <email>nicolas.dauby@stpierre-bru.be</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>St Anne University Hospital</name>
      <address>
        <city>Brno</city>
        <zip>65691</zip>
        <country>Czechia</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Michael Rezek</last_name>
      <email>rezek@fnusa.cz</email>
    </contact>
    <contact_backup>
      <last_name>Andrej Nagy</last_name>
      <email>andrej.nagy@fnusa.cz</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>CHU Amiens Picardie (ICU)</name>
      <address>
        <city>Amiens</city>
        <zip>80054</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yoann Zerbib</last_name>
      <email>zerbib.yoann@chu-amiens.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHU Amiens Picardie (ID)</name>
      <address>
        <city>Amiens</city>
        <zip>80054</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jean-Philippe Lanoix</last_name>
      <email>lanoix.jean-philippe@chu-amiens.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHU de Bordeaux / Hopital Pellegrin (ICU)</name>
      <address>
        <city>Bordeaux</city>
        <zip>33076</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alexandre Boyer</last_name>
      <email>alexandre.boyer@chu-bordeaux.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHU de Bordeaux / Hopital Pellegrin (ID)</name>
      <address>
        <city>Bordeaux</city>
        <zip>33076</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Denis Malvy</last_name>
      <email>denis.malvy@chu.bordeaux.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Louis Mourier (ID)</name>
      <address>
        <city>Colombes</city>
        <zip>92700</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Damien Roux</last_name>
      <email>damien.roux@aphp.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Lous Mourier (ICU)</name>
      <address>
        <city>Colombes</city>
        <zip>92700</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jean-Damien Richard</last_name>
      <email>jean-damien.ricard@aphp.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHU François Mitterrand</name>
      <address>
        <city>Dijon</city>
        <zip>21000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lionel Piroth</last_name>
      <email>lionel.piroth@chu-dijon.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHU Lille - Hopital Roger Salengro -Pôle Rèanimaition</name>
      <address>
        <city>Lille</city>
        <zip>59037</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Julien Poissy</last_name>
      <email>julien.poissy@chru-lille.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hopital de la Croix - Rousse - HCL (ICU)</name>
      <address>
        <city>Lyon</city>
        <zip>69004</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jean-Christophe Richard</last_name>
      <email>j-christophe.richard@chu-lyon.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hopital de la Croix - Rousse - HCL (ID)</name>
      <address>
        <city>Lyon</city>
        <zip>69004</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Florence Ader</last_name>
      <email>florence.ader@chu-lyon.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>GHRMSA Hopital Emile Muller (ICU)</name>
      <address>
        <city>Mulhouse</city>
        <zip>68100</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yogananden J Mootien</last_name>
      <email>mootieny@ghrmsa.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>GHRMSA Hopital Emile Muller (IM)</name>
      <address>
        <city>Mulhouse</city>
        <zip>68100</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Benjamin Dervieux</last_name>
      <email>benjamin.dervieux@ghrmsa.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hôpital Saint-Antoine (ICU)</name>
      <address>
        <city>Paris</city>
        <zip>75012</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Hafid Ait-Oufella</last_name>
      <email>hafid.aitoufella@inserm.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hôpital Saint-Antoine (ID)</name>
      <address>
        <city>Paris</city>
        <zip>75012</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Karine Lacombe</last_name>
      <email>karine.lacombe2@aphp.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hôpital Bichat - Claude Bernard (ICU)</name>
      <address>
        <city>Paris</city>
        <zip>75017</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jean-Francois Timsit</last_name>
      <email>jean-francois.timsit@aphp.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hôpital Bichat - Claude Bernard (ID)</name>
      <address>
        <city>Paris</city>
        <zip>75017</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nathan Peiffer-Smadja</last_name>
      <email>nathan.peiffer-smadja@aphp.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Gesundheit Nord gGmbH (GeNo)</name>
      <address>
        <city>Bremen</city>
        <zip>28177</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Rolf Dembinski</last_name>
      <email>rolf.dembinski@klinikum-bremen-mitte.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Justus-Leibig Universität (JLU)</name>
      <address>
        <city>Geißen</city>
        <zip>35392</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Susanne Herold</last_name>
      <email>susanne.herold@innere.med.uni-giessen.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Medizinische Hochschule Hannover (MHH)</name>
      <address>
        <city>Hannover</city>
        <zip>30625</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Tobias Welte</last_name>
      <email>welte.tobias@mh-hannover.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Technische Universität München (TUM) - Klinikum rechts der Isar</name>
      <address>
        <city>München</city>
        <zip>81675</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Gerhard Schneider</last_name>
      <email>gerhard.schneider@mri.tum.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Klinikum Saarbrücken gGmbH (SAAR)</name>
      <address>
        <city>Saarbrücken</city>
        <zip>66119</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Daniel Grandt</last_name>
      <email>dgrandt@klinikum-saarbruecken.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Evangelismos Hospital</name>
      <address>
        <city>Athens</city>
        <zip>10675</zip>
        <country>Greece</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Anastasia Kotanidou</last_name>
      <email>akotanid@med.uoa.gr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Attikon University Hospital</name>
      <address>
        <city>Athens</city>
        <zip>12462</zip>
        <country>Greece</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Sotirios Tsiodras</last_name>
      <email>stsiodras.office@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Debrecen (Clinic for Infectology)</name>
      <address>
        <city>Debrecen</city>
        <zip>4031</zip>
        <country>Hungary</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Istvan Varkonyi</last_name>
      <email>varkonyi.istvan@med.unideb.hu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Pécs</name>
      <address>
        <city>Pécs</city>
        <zip>7623</zip>
        <country>Hungary</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Zoltán Péterfi</last_name>
      <email>peterfi.zoltan@pte.hu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Szeged (Pandemic Clinics)</name>
      <address>
        <city>Szeged</city>
        <zip>6725</zip>
        <country>Hungary</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Habil H Edig</last_name>
      <email>horvathne.hajdu.edit@med.u-szeged.hu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Cork University Hospital</name>
      <address>
        <city>Cork</city>
        <zip>T12 DFK4</zip>
        <country>Ireland</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Arthur Jackson</last_name>
      <email>arthur.jackson@hse.ie</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>St Vincent's University Hospital</name>
      <address>
        <city>Dublin</city>
        <zip>4</zip>
        <country>Ireland</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Paddy Mallon</last_name>
      <email>paddy.mallon@ucd.ie</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Mater Misericordiae University Hospital</name>
      <address>
        <city>Dublin</city>
        <zip>D07 R2WY</zip>
        <country>Ireland</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Eavan Muldoon</last_name>
      <email>eavanmuldoon@mater.ie</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>St James's Hospital, Dublin</name>
      <address>
        <city>Dublin</city>
        <zip>D08 NHY1</zip>
        <country>Ireland</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Brian Kent</last_name>
      <email>BKent@stjames.ie</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Beaumont Hospital, Dublin</name>
      <address>
        <city>Dublin</city>
        <zip>D09VZNO</zip>
        <country>Ireland</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Eoghan de Barra</last_name>
      <email>edebarra@rcsi.ie</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Tallaght University Hospital</name>
      <address>
        <city>Dublin</city>
        <zip>D24 NR0A</zip>
        <country>Ireland</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Seamus Donnelly</last_name>
      <email>seamas.donnelly@tcd.ie</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University Hospital Galway</name>
      <address>
        <city>Galway</city>
        <zip>H91 YR71</zip>
        <country>Ireland</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>John Laffey</last_name>
      <email>john.laffey@nuigalway.ie</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University Hospital Limerick</name>
      <address>
        <city>Limerick</city>
        <zip>V94 F858</zip>
        <country>Ireland</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Sarah O'Connell</last_name>
      <email>soconne4@tcd.ie</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Ospedale Cardinal Massala di Asti, Malattie Infettive</name>
      <address>
        <city>Asti</city>
        <zip>14100</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Francesco G de Rosa</last_name>
      <email>francescogiuseppe.derosa@unito.it</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Ospedale Santa Maria Annunziata, Malattie Infettive</name>
      <address>
        <city>Bagno A Ripoli</city>
        <zip>50012</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Massino A Di Pietro</last_name>
      <email>massimoantonio.dipietro@uslcentro.toscana.it</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>ASST - Spedali Civili di Brescia - University of Brescia</name>
      <address>
        <city>Brescia</city>
        <zip>25123</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Francesco Castelli</last_name>
      <email>francesco.castelli@unibs.it</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>ATS Sardegna - PO SS Trinità, U.O.C. Malattie Infettive</name>
      <address>
        <city>Cagliari</city>
        <zip>09121</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Goffredo Angioni</last_name>
      <email>goffredo.angioni@arssardegna.it</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Azienda Opsedaliera Universitaria Mater Domini, U.O. Malattie Infettive e Tropicali</name>
      <address>
        <city>Catanzaro</city>
        <zip>88100</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Enrico M Trecarichi</last_name>
      <email>em.trecarichi@unicz.it</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>ASL Frosinone - Ospedale Fabrizio Spaziani, U.O.C. Medicina Interna</name>
      <address>
        <city>Frosinone</city>
        <zip>03100</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Rosalba Cipriani</last_name>
      <email>rosalba.cipriani@aslfrosinone.it</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Ospedale S.M. Goretti di Latina, U.O.C. Malattie Infettive</name>
      <address>
        <city>Latina</city>
        <zip>04100</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Miriam Lichtner</last_name>
      <email>miriam.lichtner@uniroma1.it</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Ospedale Mater Salutis di Legnago, U.O.C. di Pneumologia</name>
      <address>
        <city>Legnano</city>
        <zip>37045</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Silvia Tognella</last_name>
      <email>silvia.tognella@aulss9.veneto.it</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Ospedale Mater Salutis di Legnago, U.O.S. di Malattie Infettive</name>
      <address>
        <city>Legnano</city>
        <zip>37045</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Pierangelo Rovere</last_name>
      <email>pierangelo.rovere@aulss9.veneto.it</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, U.O.C. Malattie Infettive</name>
      <address>
        <city>Milano</city>
        <zip>20121</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Andrea Gori</last_name>
      <email>andrea.gori@unimi.it</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>ASST Santi Paolo e Carlo, S.C. Malattie Infettive</name>
      <address>
        <city>Milano</city>
        <zip>20142</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Antonella d'Arminio Monforte</last_name>
      <email>antonella.darminio@unimi.it</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Azienda Ospedaliera Universitaria Vanvitelli, U.O.C. Malattie Infettive</name>
      <address>
        <city>Napoli</city>
        <zip>80138</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Nicola Coppola</last_name>
      <email>nicola.coppola@unicampania.it</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>AOU Policlinico &quot;P. Giaccone&quot;, U.O.C. Malattie Infettive</name>
      <address>
        <city>Palermo</city>
        <zip>90127</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Antonio Cascio</last_name>
      <email>antonio.cascio03@unipa.it</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Azienda Ospedaliera Ospedali Riuniti Marche Nord, U.O.C. Malattie Infettive</name>
      <address>
        <city>Pesaro</city>
        <zip>61122</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Francesco Barchiesi</last_name>
      <email>francesco.barchiesi@ospedalimarchenord.it</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>ASL Taranto - Ospedale Oncologico San Giuseppe Moscati, U.O.C. Pneumologia</name>
      <address>
        <city>Taranto</city>
        <zip>74010</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Andrea Nico</last_name>
      <email>andrea.nico@asl.taranto.it</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Azienda Sanitaria Universitaria Giuliano Isontina (ASU GI), S.C. Malattie Infettive</name>
      <address>
        <city>Trieste</city>
        <zip>34128</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Marta Zatta</last_name>
      <email>marta.zatta@asugi.sanita.fvg.it</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>IRCCS Ospedale Sacro Cuore Don Calabria, U.O.S. Malattie Infettive e Tropicali</name>
      <address>
        <city>Verona</city>
        <zip>37024</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Andrea Angheben</last_name>
      <email>andrea.angheben@sacrocurore.it</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Azienda Ospedaliera Universitaria Integrata di Verona, U.O.C. Malattie Infettive e Tropicali</name>
      <address>
        <city>Verona</city>
        <zip>37314</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Evelina Tacconelli</last_name>
      <email>eveliona.tacconelli@univr.it</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier de Luxembourg</name>
      <address>
        <city>Luxembourg</city>
        <zip>L-1210</zip>
        <country>Luxembourg</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Jean Reuter</last_name>
      <email>reuter.jean@chl.lu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Haukeland University Hospital</name>
      <address>
        <city>Bergen</city>
        <zip>5021</zip>
        <country>Norway</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Bjørn Blomberg</last_name>
      <email>bjorn.blomberg@uib.no</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Drammen (Vestre Viken) Hospital</name>
      <address>
        <city>Drammen</city>
        <zip>NO-3004</zip>
        <country>Norway</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lars Heggelund</last_name>
      <email>lars.heggelund@vestreviken.no</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Østfold sykehuset i Kalnes</name>
      <address>
        <city>Grålum</city>
        <zip>1714</zip>
        <country>Norway</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Saad Aballi</last_name>
      <email>saad.aballi@so-hf.no</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Akershus Universitetssykehus</name>
      <address>
        <city>Lørenskog</city>
        <zip>1478</zip>
        <country>Norway</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Olav Dalgard</last_name>
      <email>odalgard@medisin.uio.no</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Lovisenberg Diaconal Hospital</name>
      <address>
        <city>Oslo</city>
        <zip>04400</zip>
        <country>Norway</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Simen W Schive</last_name>
      <email>simenwalberg.schive@lds.no</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>OUS Ullevål</name>
      <address>
        <city>Oslo</city>
        <zip>N-0424</zip>
        <country>Norway</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anna Ma Dyrhold Riise</last_name>
      <email>a.m.d.riise@medisin.uio.no</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Bærum Hospital</name>
      <address>
        <city>Sandvika</city>
        <zip>1346</zip>
        <country>Norway</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anders Tveita</last_name>
      <email>anders.tveita@medisin.uio.no</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Stavanger University Hospital</name>
      <address>
        <city>Stavanger</city>
        <zip>4011</zip>
        <country>Norway</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Åse Berg</last_name>
      <email>ase.berg@sus.no</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University Hospital North Norway</name>
      <address>
        <city>Tromsø</city>
        <zip>9019</zip>
        <country>Norway</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anders B Kildal</last_name>
      <email>anders.benjamin.kildal@unn.no</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>St. Olavs Hospital</name>
      <address>
        <city>Trondheim</city>
        <zip>7006</zip>
        <country>Norway</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Raisa Hannula</last_name>
      <email>raisa.hannula@stolav.no</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Vestfold Hospital</name>
      <address>
        <city>Tønsberg</city>
        <zip>3103</zip>
        <country>Norway</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Aesgir Johannessen</last_name>
      <email>UXASOH@siv.no</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHMT - Centro Hospitalar do Médio Tejo- Hospital de Abrantes</name>
      <address>
        <city>Abrantes</city>
        <zip>2200-202</zip>
        <country>Portugal</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Nuno Catorze</last_name>
      <email>nunocatorze@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHUC - Centro Hospitalar e Universitário de Coimbra</name>
      <address>
        <city>Coimbra</city>
        <zip>3000-075</zip>
        <country>Portugal</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Luis Linhares Santos</last_name>
      <email>linhares@sapo.pt</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHUA-Faro - Centro Hospitalar Universitário do Algarve</name>
      <address>
        <city>Faro</city>
        <country>Portugal</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Daniel Nuñez</last_name>
      <email>quicodaneil@hotmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHLC-HCC - Hospital Curry Cabral, Centro Hospitalar Universitário Lisboa Central</name>
      <address>
        <city>Lisboa</city>
        <zip>1050-099</zip>
        <country>Portugal</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>César Vieira</last_name>
      <email>cesar.vieira@chlc.min-saude.pt</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHLN - Centro Hospitalar Universitário Lisboa Norte</name>
      <address>
        <city>Lisboa</city>
        <zip>1649-035</zip>
        <country>Portugal</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>João Miguel Ribeiro</last_name>
      <email>jmribeiro@chln.min-saude.pt</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHLO - Centro Hospitalar de Lisboa Ocidental - HEM and HSFX</name>
      <address>
        <city>Lisbon</city>
        <zip>1349-019</zip>
        <country>Portugal</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Kamal Mansinho</last_name>
      <email>kmansinho@chlo.min-saude.pt</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHSJ - São João Hospital Center</name>
      <address>
        <city>Lisbon</city>
        <zip>1349-019</zip>
        <country>Portugal</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Robert Roncon-Albuquerque Jr</last_name>
      <email>roberto.albuquerque@chsj.min-saude.pt</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>HBA - Hospital Beatriz Ângelo</name>
      <address>
        <city>Loures</city>
        <zip>2674-514</zip>
        <country>Portugal</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Carlos Simóes Pereira</last_name>
      <email>Carlos.Pereira@hbeatrizangelo.pt</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University Hospital Bratislava, Kramare</name>
      <address>
        <city>Bratislava</city>
        <zip>83105</zip>
        <country>Slovakia</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Andrea Kalavska</last_name>
      <email>kalavska.andrea@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University Hospital Martin</name>
      <address>
        <city>Martin</city>
        <zip>036 01</zip>
        <country>Slovakia</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Dušan Krkoša</last_name>
      <email>krkoska@unm.sk</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Nsp Trebisov, Svet Zdravia a.s.</name>
      <address>
        <city>Trebišov</city>
        <zip>075 01</zip>
        <country>Slovakia</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Michal Banik</last_name>
      <email>michal.banik@svetzdravia.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Faculty Hospital Trencin</name>
      <address>
        <city>Trenčín</city>
        <zip>91171</zip>
        <country>Slovakia</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Frantisek Novacek</last_name>
      <email>luboslava.hiresova@fntn.sk</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University Hospital Trnava</name>
      <address>
        <city>Trnava</city>
        <zip>917 75</zip>
        <country>Slovakia</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Mária Soľavová</last_name>
      <email>maria.solavova@fntt.sk</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Nemocnica AGEL Košice-Šaca a.s.</name>
      <address>
        <city>Šaca</city>
        <zip>14015</zip>
        <country>Slovakia</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Nikoleta Hamašová</last_name>
      <email>hamasnika@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Reina Sofia</name>
      <address>
        <city>Córdoba</city>
        <zip>14004</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Carmen de la Fuente Martos</last_name>
      <email>carmen.fuente.sspa@juntadeandalucia.ed</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario de Jaen</name>
      <address>
        <city>Jaén</city>
        <zip>23001</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Carmen Herrero Rodríguez</last_name>
      <email>gonees.data@hotmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario La Paz</name>
      <address>
        <city>Madrid</city>
        <zip>28046</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>José Ramón Arribas</last_name>
      <email>joser.arribas@salud.madrid.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Costa del Sol</name>
      <address>
        <city>Marbella</city>
        <zip>29603</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Junlián Olalla</last_name>
      <email>julio.olalla@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Virgen de la Victoria</name>
      <address>
        <city>Málaga</city>
        <zip>29101</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Enrique Nuño Alvarez</last_name>
      <email>nuno@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Virgen Macarena</name>
      <address>
        <city>Sevilla</city>
        <zip>41009</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Jésus Rodriguez Baño</last_name>
      <email>jesusrb@us.es</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Virgen del Rocio</name>
      <address>
        <city>Sevilla</city>
        <zip>41013</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>José Miguel Cisneros Herreros</last_name>
      <email>jmcisnerosh@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Virgen de Valme</name>
      <address>
        <city>Sevilla</city>
        <zip>41014</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Nicolás Merchante</last_name>
      <email>nicolasmerchante@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hacettepe Üniversitesi Tıp Fakültesi, İnfeksiyon Hastalıkları ve Klinik Mikrobiyoloji Anabilim Dalı (Site 1)</name>
      <address>
        <city>Ankara</city>
        <zip>06230</zip>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Serhat Ünal</last_name>
      <email>sunal@hacettepe.edu.tr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hacettepe Üniversitesi Tıp Fakültesi, İnfeksiyon Hastalıkları ve Klinik Mikrobiyoloji Anabilim Dalı (Site 2)</name>
      <address>
        <city>Ankara</city>
        <zip>06230</zip>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Ahmet Çağkan İnkaya</last_name>
      <email>inkayaac@yahoo.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Ankara Üniversitesi Tıp Fakültesi, Enfeksiyon Hastalıkları ve Klinik Mikrobiyoloji Anabilim Dalı</name>
      <address>
        <city>Ankara</city>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Alpay Azap</last_name>
      <email>azap@medicine.ankara.edu.tr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>İstanbul Üniversitesi İstanbul Tıp Fakültesi, Enfeksiyon Hastalıkları ve Klinik Mikrobiyoloji Anabilim Dalı</name>
      <address>
        <city>Istanbul</city>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Serap Şimşek Yavuz</last_name>
      <email>serapsimsekyavuz@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Dokuz Eylül Üniversitesi Tıp Fakültesi Enfeksiyon Hastalıkları ve Klinik Mikrobiyoloji Anabilim Dalı</name>
      <address>
        <city>İzmir</city>
        <zip>35340</zip>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Vildan Avkan Oğuz</last_name>
      <email>vildan.oguz@deu.edu.tr</email>
    </contact>
  </location>
  <location_countries>
    <country>Austria</country>
    <country>Belgium</country>
    <country>Czechia</country>
    <country>France</country>
    <country>Germany</country>
    <country>Greece</country>
    <country>Hungary</country>
    <country>Ireland</country>
    <country>Italy</country>
    <country>Luxembourg</country>
    <country>Norway</country>
    <country>Portugal</country>
    <country>Slovakia</country>
    <country>Spain</country>
    <country>Turkey</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>May 7, 2021</study_first_submitted>
  <study_first_submitted_qc>May 12, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">May 18, 2021</study_first_posted>
  <last_update_submitted>September 10, 2021</last_update_submitted>
  <last_update_submitted_qc>September 10, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 13, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Oslo University Hospital</investigator_affiliation>
    <investigator_full_name>Marius Trøseid</investigator_full_name>
    <investigator_title>Associated professor, MD, PhD</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infections</mesh_term>
    <mesh_term>Communicable Diseases</mesh_term>
    <mesh_term>Communicable Diseases, Emerging</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>Individual patient-level data will be made as public as possible while maintaining the integrity and privacy of the trial participants. Anonymized data will be made publicly available using a data repository, including any programming code used to produce the trial results. De-identified data will be made available upon request and evaluation of the requestee's ability and willingness to maintain the integrity and privacy of the trial participants. Further details of data sharing will be given in a separate data sharing plan.</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Statistical Analysis Plan (SAP)</ipd_info_type>
    <ipd_info_type>Informed Consent Form (ICF)</ipd_info_type>
    <ipd_info_type>Clinical Study Report (CSR)</ipd_info_type>
    <ipd_info_type>Analytic Code</ipd_info_type>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

